Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2018-09-09 Tx date 2018-09-05 |
$ARV
AREV Nutrition Sciences Inc. (formerly Immunall Science Inc.) |
Harvey, Matthew
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$4,500,000
+9,000,000 vol $0.50 each |
9,000,000 | |
Filed 2018-09-09 Tx date 2018-07-26 |
$ARV
AREV Nutrition Sciences Inc. (formerly Immunall Science Inc.) |
Harvey, Matthew
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-08-09 Tx date 2018-08-07 |
$ARV
AREV Nutrition Sciences Inc. (formerly Immunall Science Inc.) |
Davis, Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-08-09 Tx date 2018-08-07 |
$ARV
AREV Nutrition Sciences Inc. (formerly Immunall Science Inc.) |
Davis, Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-08-09 Tx date 2018-08-07 |
$ARV
AREV Nutrition Sciences Inc. (formerly Immunall Science Inc.) |
Davis, Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-05-22 Tx date 2018-05-15 |
$ARV
AREV Nutrition Sciences Inc. (formerly Immunall Science Inc.) |
mcdermid, scott
4 - Director of Issuer
Direct Ownership
|
Warrants
36 - Conversion or exchange
|
$-20,000
-200,000 vol $0.10 each |
0 | |
Filed 2018-05-22 Tx date 2018-05-15 |
$ARV
AREV Nutrition Sciences Inc. (formerly Immunall Science Inc.) |
mcdermid, scott
4 - Director of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
$20,000
+200,000 vol $0.10 each |
200,000 | |
Filed 2018-02-20 Tx date 2018-02-05 |
$ARV
AREV Nutrition Sciences Inc. (formerly Immunall Science Inc.) |
Sider, Derek
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$212,800
+380,000 vol $0.56 each |
380,000 | |
Filed 2018-02-20 Tx date 2018-02-05 |
$ARV
AREV Nutrition Sciences Inc. (formerly Immunall Science Inc.) |
Sider, Derek
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-02-06 Tx date 2017-09-18 |
$ARV
AREV Nutrition Sciences Inc. (formerly Immunall Science Inc.) |
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-02-06 Tx date 2017-09-18 |
$ARV
AREV Nutrition Sciences Inc. (formerly Immunall Science Inc.) |
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$25,000
+100,000 vol $0.25 each |
100,000 | |
Filed 2018-01-15 Tx date 2018-01-10 |
$ARV
AREV Nutrition Sciences Inc. (formerly Immunall Science Inc.) |
Withrow, MIke Withrow
4 - Director of Issuer
Holder: Chiron Capital Inc (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$-62,500
-250,000 vol $0.25 each |
4,884,000 | |
Filed 2018-01-08 Tx date 2017-11-28 |
$ARV
AREV Nutrition Sciences Inc. (formerly Immunall Science Inc.) |
Withrow, MIke Withrow
4 - Director of Issuer
Holder: Chateau Jing Capital Inc. (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$20,000
+80,000 vol $0.25 each |
80,000 | |
Filed 2018-01-08 Tx date 2017-11-28 |
$ARV
AREV Nutrition Sciences Inc. (formerly Immunall Science Inc.) |
Withrow, MIke Withrow
4 - Director of Issuer
Holder: Chateau Jing Capital Inc. (Indirect Ownership)
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$16,000
+40,000 vol $0.40 each |
40,000 | |
Filed 2018-01-08 Tx date 2016-11-11 |
$ARV
AREV Nutrition Sciences Inc. (formerly Immunall Science Inc.) |
Withrow, MIke Withrow
4 - Director of Issuer
Holder: Chateau Jing Capital Inc. (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-01-08 Tx date 2017-12-22 |
$ARV
AREV Nutrition Sciences Inc. (formerly Immunall Science Inc.) |
Withrow, MIke Withrow
4 - Director of Issuer
Holder: Chiron Capital Inc (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$19,500
+39,000 vol $0.50 each |
5,134,000 | |
Filed 2018-01-08 Tx date 2017-12-09 |
$ARV
AREV Nutrition Sciences Inc. (formerly Immunall Science Inc.) |
Withrow, MIke Withrow
4 - Director of Issuer
Holder: Chiron Capital Inc (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$-250,000
-1,000,000 vol $0.25 each |
5,095,000 | |
Filed 2018-01-08 Tx date 2017-11-30 |
$ARV
AREV Nutrition Sciences Inc. (formerly Immunall Science Inc.) |
Withrow, MIke Withrow
4 - Director of Issuer
Holder: Chiron Capital Inc (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$-75,000
-300,000 vol $0.25 each |
6,095,000 | |
Filed 2018-01-08 Tx date 2016-11-11 |
$ARV
AREV Nutrition Sciences Inc. (formerly Immunall Science Inc.) |
Withrow, MIke Withrow
4 - Director of Issuer
Holder: Chateau Jing Capital Inc. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-12-14 Tx date 2016-03-29 |
$ARV
AREV Nutrition Sciences Inc. (formerly Immunall Science Inc.) |
Maher, Stephane
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-12-14 Tx date 2017-12-11 |
$ARV
AREV Nutrition Sciences Inc. (formerly Immunall Science Inc.) |
Rehmann, Nils
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,800
-10,000 vol $0.58 each |
190,000 | |
Filed 2017-12-14 Tx date 2017-11-28 |
$ARV
AREV Nutrition Sciences Inc. (formerly Immunall Science Inc.) |
Maher, Stephane
4 - Director of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
$21,600
+54,000 vol $0.40 each |
54,000 | |
Filed 2017-12-14 Tx date 2017-11-28 |
$ARV
AREV Nutrition Sciences Inc. (formerly Immunall Science Inc.) |
Maher, Stephane
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$27,000
+108,000 vol $0.25 each |
2,108,000 | |
Filed 2017-12-07 Tx date 2017-12-07 |
$ARV
AREV Nutrition Sciences Inc. (formerly Immunall Science Inc.) |
mcdermid, scott
4 - Director of Issuer
Direct Ownership
|
Common Shares
70 - Acquisition or disposition (writing) of third party derivative
|
$-104,000
-200,000 vol $0.52 each |
0 | |
Filed 2017-11-13 Tx date 2017-11-13 |
$ARV
AREV Nutrition Sciences Inc. (formerly Immunall Science Inc.) |
Withrow, MIke Withrow
4 - Director of Issuer
Holder: Chiron Capital Inc (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$15,800
+40,000 vol $0.395 each |
6,395,000 | |
Filed 2017-11-08 Tx date 2017-11-03 |
$ARV
AREV Nutrition Sciences Inc. (formerly Immunall Science Inc.) |
Withrow, MIke Withrow
4 - Director of Issuer
Holder: Chiron Capital Inc (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$12,000
+25,000 vol $0.48 each |
6,343,500 | |
Filed 2017-11-08 Tx date 2017-11-03 |
$ARV
AREV Nutrition Sciences Inc. (formerly Immunall Science Inc.) |
Withrow, MIke Withrow
4 - Director of Issuer
Holder: Chiron Capital Inc (Indirect Ownership)
|
Common Shares
54 - Exercise of warrants
|
$50,000
+500,000 vol $0.10 each |
6,300,000 | |
Filed 2017-11-08 Tx date 2017-11-03 |
$ARV
AREV Nutrition Sciences Inc. (formerly Immunall Science Inc.) |
Withrow, MIke Withrow
4 - Director of Issuer
Holder: Chiron Capital Inc (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,037
+8,500 vol $0.475 each |
6,308,500 | |
Filed 2017-11-08 Tx date 2017-11-03 |
$ARV
AREV Nutrition Sciences Inc. (formerly Immunall Science Inc.) |
Withrow, MIke Withrow
4 - Director of Issuer
Holder: Chiron Capital Inc (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,850
+10,000 vol $0.485 each |
6,318,500 | |
Filed 2017-11-08 Tx date 2017-11-06 |
$ARV
AREV Nutrition Sciences Inc. (formerly Immunall Science Inc.) |
Withrow, MIke Withrow
4 - Director of Issuer
Holder: Chiron Capital Inc (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,850
+10,000 vol $0.485 each |
6,353,500 | |
Filed 2017-11-08 Tx date 2017-11-06 |
$ARV
AREV Nutrition Sciences Inc. (formerly Immunall Science Inc.) |
Withrow, MIke Withrow
4 - Director of Issuer
Holder: Chiron Capital Inc (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$712.50
+1,500 vol $0.475 each |
6,355,000 | |
Filed 2017-11-08 Tx date 2017-11-03 |
$ARV
AREV Nutrition Sciences Inc. (formerly Immunall Science Inc.) |
Withrow, MIke Withrow
4 - Director of Issuer
Holder: Chiron Capital Inc (Indirect Ownership)
|
Warrants
54 - Exercise of warrants
|
$50,000
+500,000 vol $0.10 each |
||
Filed 2017-11-08 Tx date 2017-11-03 |
$ARV
AREV Nutrition Sciences Inc. (formerly Immunall Science Inc.) |
Withrow, MIke Withrow
4 - Director of Issuer
Holder: Chiron Capital Inc (Indirect Ownership)
|
Warrants
54 - Exercise of warrants
|
$-50,000
-500,000 vol $0.10 each |
1,800,000 | |
Filed 2017-11-08 Tx date 2017-11-06 |
$ARV
AREV Nutrition Sciences Inc. (formerly Immunall Science Inc.) |
Withrow, MIke Withrow
4 - Director of Issuer
Holder: Chiron Capital Inc (Indirect Ownership)
|
Warrants
11 - Acquisition or disposition carried out privately
|
$-45,000
-900,000 vol $0.05 each |
900,000 | |
Filed 2017-09-17 Tx date 2017-09-14 |
$ARV
AREV Nutrition Sciences Inc. (formerly Immunall Science Inc.) |
Withrow, MIke Withrow
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,225
+5,000 vol $0.245 each |
98,000 | |
Filed 2017-09-17 Tx date 2017-09-14 |
$ARV
AREV Nutrition Sciences Inc. (formerly Immunall Science Inc.) |
Withrow, MIke Withrow
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,610
+25,500 vol $0.22 each |
93,000 | |
Filed 2017-09-13 Tx date 2017-09-13 |
$ARV
AREV Nutrition Sciences Inc. (formerly Immunall Science Inc.) |
Withrow, MIke Withrow
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,125
+24,500 vol $0.25 each |
67,500 | |
Filed 2017-09-13 Tx date 2017-09-13 |
$ARV
AREV Nutrition Sciences Inc. (formerly Immunall Science Inc.) |
Withrow, MIke Withrow
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$115.00
+500 vol $0.23 each |
43,000 | |
Filed 2017-09-05 Tx date 2016-11-12 |
$ARV
AREV Nutrition Sciences Inc. (formerly Immunall Science Inc.) |
Withrow, MIke Withrow
4 - Director of Issuer
Holder: Chiron Capital Inc (Control or Direction)
|
Convertible Debentures
46 - Compensation for services
|
$
+$6,000,000 vol $0.05 each |
||
Filed 2017-09-05 Tx date 2016-11-12 |
$ARV
AREV Nutrition Sciences Inc. (formerly Immunall Science Inc.) |
Withrow, MIke Withrow
4 - Director of Issuer
Holder: Chiron Capital Inc (Control or Direction)
|
Convertible Debentures
46 - Compensation for services
|
$
+$300,000 vol $0.05 each |
$300,000 | |
Filed 2017-09-05 Tx date 2016-09-16 |
$ARV
AREV Nutrition Sciences Inc. (formerly Immunall Science Inc.) |
Withrow, MIke Withrow
4 - Director of Issuer
Holder: Chiron Capital Inc (Control or Direction)
|
Convertible Debentures
46 - Compensation for services
|
$
+$6,000,000 vol $0.05 each |
||
Filed 2017-08-28 Tx date 2016-09-16 |
$ARV
AREV Nutrition Sciences Inc. (formerly Immunall Science Inc.) |
Withrow, MIke Withrow
4 - Director of Issuer
Holder: Chiron Capital Inc (Control or Direction)
|
Convertible Debentures
46 - Compensation for services
|
$
+$6,000,000 vol $0.05 each |
||
Filed 2017-08-28 Tx date 2016-11-12 |
$ARV
AREV Nutrition Sciences Inc. (formerly Immunall Science Inc.) |
Withrow, MIke Withrow
4 - Director of Issuer
Holder: Chiron Capital Inc (Control or Direction)
|
Convertible Debentures
46 - Compensation for services
|
$
+$6,000,000 vol $0.05 each |
$6,000,000 | |
Filed 2017-08-25 Tx date 2017-08-23 |
$ARV
AREV Nutrition Sciences Inc. (formerly Immunall Science Inc.) |
Withrow, MIke Withrow
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,500
+42,500 vol $0.20 each |
42,500 | |
Filed 2017-08-18 Tx date 2016-12-09 |
$ARV
AREV Nutrition Sciences Inc. (formerly Immunall Science Inc.) |
Withrow, MIke Withrow
4 - Director of Issuer
Holder: Chiron Capital Inc (Control or Direction)
|
Common Shares
45 - Compensation for property
|
$100,000
+2,000,000 vol $0.05 each |
2,000,000 | |
Filed 2017-08-18 Tx date 2017-04-20 |
$ARV
AREV Nutrition Sciences Inc. (formerly Immunall Science Inc.) |
Withrow, MIke Withrow
4 - Director of Issuer
Holder: Chiron Capital Inc (Control or Direction)
|
Warrants
46 - Compensation for services
|
$115,000
+2,300,000 vol $0.05 each |
2,300,000 | |
Filed 2017-08-18 Tx date 2016-11-11 |
$ARV
AREV Nutrition Sciences Inc. (formerly Immunall Science Inc.) |
Withrow, MIke Withrow
4 - Director of Issuer
Holder: Chiron Capital Inc (Control or Direction)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-08-18 Tx date 2016-11-11 |
$ARV
AREV Nutrition Sciences Inc. (formerly Immunall Science Inc.) |
Withrow, MIke Withrow
4 - Director of Issuer
Holder: Chiron Capital Inc (Control or Direction)
|
Convertible Debentures
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-08-18 Tx date 2016-09-16 |
$ARV
AREV Nutrition Sciences Inc. (formerly Immunall Science Inc.) |
Withrow, MIke Withrow
4 - Director of Issuer
Holder: Chiron Capital Inc (Control or Direction)
|
Convertible Debentures
46 - Compensation for services
|
$
+$6,000,000 vol $0.05 each |
$6,000,000 | |
Filed 2017-08-18 Tx date 2016-11-11 |
$ARV
AREV Nutrition Sciences Inc. (formerly Immunall Science Inc.) |
Withrow, MIke Withrow
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-08-18 Tx date 2017-04-20 |
$ARV
AREV Nutrition Sciences Inc. (formerly Immunall Science Inc.) |
Withrow, MIke Withrow
4 - Director of Issuer
Holder: Chiron Capital Inc (Control or Direction)
|
Common Shares
46 - Compensation for services
|
$115,000
+2,300,000 vol $0.05 each |
5,800,000 | |
Filed 2017-08-18 Tx date 2016-12-09 |
$ARV
AREV Nutrition Sciences Inc. (formerly Immunall Science Inc.) |
Withrow, MIke Withrow
4 - Director of Issuer
Holder: Chiron Capital Inc (Control or Direction)
|
Common Shares
45 - Compensation for property
|
$75,000
+1,500,000 vol $0.05 each |
3,500,000 | |
Filed 2017-08-18 Tx date 2016-11-11 |
$ARV
AREV Nutrition Sciences Inc. (formerly Immunall Science Inc.) |
Withrow, MIke Withrow
4 - Director of Issuer
Holder: Chiron Capital Inc (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-08-10 Tx date 2016-11-15 |
$ARV
AREV Nutrition Sciences Inc. (formerly Immunall Science Inc.) |
mcdermid, scott
4 - Director of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
$20,000
+200,000 vol $0.10 each |
200,000 | |
Filed 2017-08-10 Tx date 2016-11-10 |
$ARV
AREV Nutrition Sciences Inc. (formerly Immunall Science Inc.) |
mcdermid, scott
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-08-10 Tx date 2016-11-15 |
$ARV
AREV Nutrition Sciences Inc. (formerly Immunall Science Inc.) |
mcdermid, scott
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$10,000
+200,000 vol $0.05 each |
200,000 | |
Filed 2017-08-10 Tx date 2016-11-10 |
$ARV
AREV Nutrition Sciences Inc. (formerly Immunall Science Inc.) |
mcdermid, scott
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-08-07 Tx date 2016-11-15 |
$ARV
AREV Nutrition Sciences Inc. (formerly Immunall Science Inc.) |
Rehmann, Nils
4 - Director of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
$10,000
+200,000 vol $0.05 each |
200,000 | |
Filed 2017-08-07 Tx date 2016-03-29 |
$ARV
AREV Nutrition Sciences Inc. (formerly Immunall Science Inc.) |
Rehmann, Nils
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-05-16 Tx date 2016-03-29 |
$ARV
AREV Nutrition Sciences Inc. (formerly Immunall Science Inc.) |
Maher, Stephane
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-05-16 Tx date 2016-12-09 |
$ARV
AREV Nutrition Sciences Inc. (formerly Immunall Science Inc.) |
Maher, Stephane
4 - Director of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
$25,000
+500,000 vol $0.05 each |
2,000,000 | |
Filed 2017-05-16 Tx date 2016-12-08 |
$ARV
AREV Nutrition Sciences Inc. (formerly Immunall Science Inc.) |
Maher, Stephane
4 - Director of Issuer
Direct Ownership
|
Common Shares
45 - Compensation for property
|
$75,000
+1,500,000 vol $0.05 each |
1,500,000 |